Aspirin, NSAIDs, and colon cancer prevention: Mechanisms?

Gastroenterology

Volumn 114, Issue 5, 1998, Pages 1095-1098

  Gupta, R A ^a   DuBois, R N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; EDITORIAL; HUMAN; INTESTINE POLYP; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

EID: 0031957722     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70330-0     Document Type: Editorial

References (40)

1. CJ Barnes M Lee Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin Gastroenterology 114 1998 873 877
2. WR Waddell RW Loughry Sulindac for polyposis of the colon J Surg Oncol 24 1983 83 87
3. JR Vane Inhibition of prostaglandin synthesis as a mechanism of action of the aspirin-like drugs Nature New Biol 231 1971 232 235
4. SJ Shiff G Rigas Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions Gastroenterology 113 1997 1992 1998
5. AP Moser HC Pitot WF Dove A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse Science 247 1990 322 324
6. L Su KW Kinzler B Vogelstein AC Preisinger AP Moser C Luongo KA Gould WF Dove Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene Science 256 1992 668 670
7. SM Powell N Zilz Y Beaser-Barclay TM Bryan SR Hamilton SM Thibodeau B Vogelstein KW Kinzler APC mutations occur early during colorectal tumorigenesis Nature 359 1992 235 237
8. KW Kinzler B Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
9. RF Jacoby DJ Marshall MA Newton K Novakovic K Tutsch CE Cole RA Lubet GJ Kelloff A Verma AR Moser WF Dove Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam Cancer Res 56 1996 710 714
10. SK Boolbol AJ Dannenberg A Chadburn C Martucci X Guo JT Ramonetti M Abreu-Goris HL Newmark ML Lipkin JJ DeCosse MM Bertagnolli Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis Cancer Res 56 1996 2556 2560
11. Y Beazer-Barclay DB Levy AR Moser WF Dove SR Hamilton B Vogelstein KW Kinzler Sulindac suppresses tumorigenesis in the Min mouse Carcinogenesis 17 1996 1757 1760
12. H Shibata K Toyama H Shioya M Ito M Hirota S Hasegawa H Matsumoto H Takano T Akiyama K Toyoshima R Kanamaru Y Kanegae I Saito Y Nakamura K Shiba T Noda Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene Science 278 1997 120 123
13. BS Reddy CV Rao A Rivenson G Kelloff Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 14 1993 1493 1497
14. CV Rao A Rivenson B Simi E Zang G Kelloff V Steele BS Reddy Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent Cancer Res 55 1995 1464 1472
15. BS Reddy H Maruyama G Kelloff Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiin-flammatory drug during different stages of rat colon tumor development Cancer Res 47 1987 5340 5346
16. BS Reddy CV Rao K Seibert Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis Cancer Res 56 1996 4566 4569
17. FM Giardiello SR Hamilton AJ Krush S Piantadosi LM Hylind P Celano SV Booker CR Robinson GJA Offerhaus Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1993 1313 1316
18. RN DuBois WE Smalley Cyclooxygenase, NSAIDs, and colorectal cancer J Gastroenterol 31 1996 898 906
19. CS Williams W Smalley RN DuBois Aspirin use and potential mechanisms for colorectal cancer prevention J Clin Invest 100 1997 1325 1329
20. B Rigas IS Goldman L Levine Altered eicosanoid levels in human colon cancer J Lab Clin Med 122 1993 518 523
21. L Qiao V Kozoni GJ Tsioulias MI Koutsos R Hanif SJ Shiff B Rigas Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo Biochem Biophys Acta 1258 1995 215 223
22. C Bortuzzo R Hanif K Kashfi L Staiano-Coico SJ Shiff B Rigas The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells Biochem Biophys Acta 1300 1996 240 246
23. DA Kujubu BS Fletcher BC Varnum RW Lim HR Herschman TS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase homologue J Biol Chem 266 1991 12866 12872
24. JL Masferrer BS Zweifel PT Manning SD Hauser KM Leahy WG Smith PC Isakson K Seibert Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic Proc Natl Acad Sci USA 91 1994 3228 3232
25. CS Williams D Luongo A Radhika T Zhang LW Lamps LB Nanney RD Beauchamp RN DuBois Elevated cyclooxygenase-2 levels in Min mouse adenomas Gastroenterology 111 1996 1134 1140
26. RN DuBois A Radhika BS Reddy AJ Entingh Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 111 1996 1134 1140
27. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
28. H Sano Y Kawahito RL Wilder A Hashiramoto S Mukai K Asai S Kimura H Kato MH Kondo T Hla Expression of cyclooxygen-ase-1 and -2 in human colorectal cancer Cancer Res 55 1995 3785 3789
29. S Kargman G O'Neil P Vickers J Evans J Mancini S Jothy Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer Cancer Res 55 1995 2556 2559
30. M Tsujii RN DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
31. M Tsujii S Kawano RN DuBois Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc Natl Acad Sci USA 94 1997 3336 3340
32. H Sheng J Shao JD Morrow RD Beauchamp RN DuBois Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells Cancer Res 58 1998 362 366
33. H Sheng J Shao SC Kirkland P Isakson RJ Coffey J Morrow RD Beauchamp RN DuBois Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 J Clin Invest 99 1997 2254 2259
34. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
35. R Hanif A Pittas Y Feng MI Koutsos L Qiao L Staiano-Coico SI Shiff B Rigas Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway Biochem Pharmacol 52 1996 237 245
36. E Kipp S Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 1994 956 959
37. P Schwenger P Bellosta I Vietor C Basilico EY Skolnik J Vilcek Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation Proc Natl Acad Sci USA 94 1997 2869 2873
38. JM Lehman JM Lenhard BB Oliver GM Ringold SA Kliewer Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs J Biol Chem 272 1997 3406 3410
39. C Chiu MF McEntee J Whelan Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis Cancer Res 57 1997 4267 4273
40. GA Piazza DS Alberts LJ Hixson NS Paranka HTF Li C Bogert JM Guiller K Brendel PH Gross G Sperl J Ritchie RW Burt L Ellsworth DJ Ahnen R Pamukcu Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels Cancer Res 57 1997 2909 2915